vigabatrin has been researched along with Perceptual Disorders in 6 studies
Perceptual Disorders: Cognitive disorders characterized by an impaired ability to perceive the nature of objects or concepts through use of the sense organs. These include spatial neglect syndromes, where an individual does not attend to visual, auditory, or sensory stimuli presented from one side of the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "From a group of 201 vigabatrin-exposed individuals with epilepsy, fourteen individuals were identified who were currently taking vigabatrin." | 3.79 | Evolution of visual field loss over ten years in individuals taking vigabatrin. ( Acheson, J; Clayton, LM; Newman, WD; Sander, JW; Sisodiya, SM; Stern, WM, 2013) |
| "Thirty three unselected patients attending neurology and epilepsy clinics were identified as taking vigabatrin and asked to attend for neuro-ophthalmic evaluation." | 3.70 | Visual field defects associated with vigabatrin therapy. ( Degg, C; Eke, T; Harding, GF; Lawden, MC; Wild, JM, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clayton, LM | 1 |
| Stern, WM | 1 |
| Newman, WD | 1 |
| Sander, JW | 1 |
| Acheson, J | 1 |
| Sisodiya, SM | 1 |
| Treiman, DM | 1 |
| Riikonen, R | 1 |
| Sorri, I | 1 |
| Brigell, MG | 1 |
| Mályusz, M | 1 |
| Mahlamäki, E | 1 |
| de Meynard, C | 1 |
| Kälviäinen, R | 1 |
| Acheson, JF | 1 |
| Lawden, MC | 1 |
| Eke, T | 1 |
| Degg, C | 1 |
| Harding, GF | 1 |
| Wild, JM | 1 |
6 other studies available for vigabatrin and Perceptual Disorders
| Article | Year |
|---|---|
Evolution of visual field loss over ten years in individuals taking vigabatrin.
Topics: Adult; Anticonvulsants; Disease Progression; Epilepsy; Female; Humans; Longitudinal Studies; Male; M | 2013 |
Progressive vigabatrin-associated visual field loss and the importance of continuing assessment of risks and benefit of epilepsy treatments.
Topics: Anticonvulsants; Epilepsy; Humans; Perceptual Disorders; Vigabatrin; Visual Fields | 2013 |
Is the risk of vigabatrin-attributed visual field loss lower in infancy than in later life?
Topics: Adult; Anticonvulsants; Child; Disease Progression; Humans; Infant; Perceptual Disorders; Spasms, In | 2009 |
Is reduced ornithine-δ-aminotransferase activity the cause of vigabatrin-associated visual field defects?
Topics: 4-Aminobutyrate Transaminase; Adolescent; Adult; Aged; Anticonvulsants; Epilepsy; Female; gamma-Amin | 2010 |
Vigabatrin associated visual field constriction.
Topics: Anticonvulsants; Constriction, Pathologic; Electroretinography; Humans; Perceptual Disorders; Retina | 1999 |
Visual field defects associated with vigabatrin therapy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Brain; Electrooculography; Electroretinography; Epilepsy; | 1999 |